Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Depreciation & Amortization (CF) (2022 - 2023)

Adial Pharmaceuticals' Depreciation & Amortization (CF) history spans 2 years, with the latest figure at $141.0 for Q4 2023.

  • For Q4 2023, Depreciation & Amortization (CF) changed 0.0% year-over-year to $141.0; the TTM value through Sep 2024 reached $141.0, down 75.0%, while the annual FY2023 figure was $564.0, 0.0% changed from the prior year.
  • Depreciation & Amortization (CF) for Q4 2023 was $141.0 at Adial Pharmaceuticals, roughly flat from $141.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1932.0 in Q1 2023 and bottomed at -$1650.0 in Q2 2023.